CHASE INVESTMENT COUNSEL CORP

Position in BMY — Bristol Myers Squibb Co

CIK 19475 CHARLOTTESVILLE, VA

Position in BMY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$221,145

-$11,629 QoQ

Shares Held

3,838

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#2,085

of 2,506 holders

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHASE INVESTMENT COUNSEL CORP holds $12,873,117 across 6 Drug Manufacturers - General names. BMY ranks #6 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	30,025	$7,555,491
2	LLY	ELI LILLY & Co	1,660	$1,991,053
3	MRK	Merck & Co., Inc.	9,815	$1,261,227
4	JNJ	Johnson & Johnson	4,714	$1,197,214
5	GILD	Gilead Sciences, Inc.	5,121	$646,987
6	BMY	Bristol Myers Squibb Co This page	3,838	$221,145

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$221,145	3,838	0.0%	Shares	Sole	2026-08-06
2026-03-31	$232,774	3,838	0.0%	Shares	Sole	2026-05-12
2025-12-31	$207,021	3,838	-36.8%	Shares	Sole	2026-02-05
2025-09-30	$273,847	6,072	+76.6%	Shares	Sole	2025-11-10
2025-03-31	$209,683	3,438	-2.1%	Shares	Sole	2025-05-12
2021-09-30	$207,686	3,510	-96.0%	Shares	Sole	2021-11-04
2020-03-31	$4,890,683	87,741	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.